<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>the ADDexecutive &#187; In the News</title>
	<atom:link href="http://www.addexecutive.com/category/in-the-news/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.addexecutive.com</link>
	<description>workplace success for executives with attention deficit disorder</description>
	<lastBuildDate>Thu, 05 Mar 2009 03:25:56 +0000</lastBuildDate>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.0.1</generator>
		<item>
		<title>The Meaning of Michael Phelps</title>
		<link>http://www.addexecutive.com/2008/11/25/the-meaning-of-michael-phelps/</link>
		<comments>http://www.addexecutive.com/2008/11/25/the-meaning-of-michael-phelps/#comments</comments>
		<pubDate>Tue, 25 Nov 2008 19:41:35 +0000</pubDate>
		<dc:creator>Phil</dc:creator>
				<category><![CDATA[ADDexecs of Note]]></category>
		<category><![CDATA[In the News]]></category>

		<guid isPermaLink="false">http://www.addexecutive.com/2008/11/25/the-meaning-of-michael-phelps/</guid>
		<description><![CDATA[In today&#8217;s New York Times, commentary on the emergence of Michael Phelps as icon for kids with attention deficit disorder, and how people perceive ADHD and other disorders: On the one hand: The notion that a disability can be harnessed in a positive way is not a new concept. Last year, a study found that [...]]]></description>
		<wfw:commentRss>http://www.addexecutive.com/2008/11/25/the-meaning-of-michael-phelps/feed/</wfw:commentRss>
		<slash:comments>3</slash:comments>
		</item>
		<item>
		<title>Adult ADHD Cost to the Workplace &#8212; New Study</title>
		<link>http://www.addexecutive.com/2008/05/26/adult-adhd-cost-to-the-workplace-new-study/</link>
		<comments>http://www.addexecutive.com/2008/05/26/adult-adhd-cost-to-the-workplace-new-study/#comments</comments>
		<pubDate>Tue, 27 May 2008 03:31:10 +0000</pubDate>
		<dc:creator>Phil</dc:creator>
				<category><![CDATA[In the News]]></category>

		<guid isPermaLink="false">http://www.addexecutive.com/2008/05/26/adult-adhd-cost-to-the-workplace-new-study/</guid>
		<description><![CDATA[In today&#8217;s news on adult attention deficit disorder: This lack of ability to concentrate costs the average adult sufferer 22.1 days of &#8220;role performance,&#8221; per year, including 8.7 extra days absent, according to researchers led by Dr. Ron de Graaf of the Netherlands Institute of Mental Health and Addiction. It might be cost-effective for employers [...]]]></description>
		<wfw:commentRss>http://www.addexecutive.com/2008/05/26/adult-adhd-cost-to-the-workplace-new-study/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>ADD at Bat</title>
		<link>http://www.addexecutive.com/2008/05/16/add-at-bat/</link>
		<comments>http://www.addexecutive.com/2008/05/16/add-at-bat/#comments</comments>
		<pubDate>Fri, 16 May 2008 22:27:36 +0000</pubDate>
		<dc:creator>Phil</dc:creator>
				<category><![CDATA[ADDexecs of Note]]></category>
		<category><![CDATA[In the News]]></category>

		<guid isPermaLink="false">http://www.addexecutive.com/2008/05/16/add-at-bat/</guid>
		<description><![CDATA[This blog occasionally mentions how our ADD nature can be an advantage. But I hadn&#8217;t thought about this one: As Major League Baseball begins to dig out from its steroids scandal, new kinds of performance-enhancing substances are sweeping big-league clubhouses: Ritalin, Adderall and other drugs designed to help with Attention-Deficit Disorder. According to records MLB [...]]]></description>
		<wfw:commentRss>http://www.addexecutive.com/2008/05/16/add-at-bat/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Dyslexia (and other disorders?) as Business Advantage &#8212; New Research</title>
		<link>http://www.addexecutive.com/2007/12/10/dyslexia-and-other-disorders-as-business-advantage-new-research/</link>
		<comments>http://www.addexecutive.com/2007/12/10/dyslexia-and-other-disorders-as-business-advantage-new-research/#comments</comments>
		<pubDate>Mon, 10 Dec 2007 17:05:27 +0000</pubDate>
		<dc:creator>Phil</dc:creator>
				<category><![CDATA[In the News]]></category>
		<category><![CDATA[Office Affirmations -- Thought for the Day]]></category>
		<category><![CDATA[Outside Insights]]></category>

		<guid isPermaLink="false">http://www.addexecutive.com/2007/12/10/dyslexia-and-other-disorders-as-business-advantage-new-research/</guid>
		<description><![CDATA[As a &#8220;brain personality,&#8221; attention deficit disorder drives people into executive positions and business ownership via its strengths (e.g., ability to multitask) and its weakenesses (e.g., lack of patience). Research just reported in the New York Times looks into the role of dyslexia as a similar driver, particularly for its role in causing people to [...]]]></description>
		<wfw:commentRss>http://www.addexecutive.com/2007/12/10/dyslexia-and-other-disorders-as-business-advantage-new-research/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Impulse Control and Willpower &#8212; You Can Do It.  New York Times</title>
		<link>http://www.addexecutive.com/2007/12/06/impulse-control-and-willpower-you-can-do-it-new-york-times/</link>
		<comments>http://www.addexecutive.com/2007/12/06/impulse-control-and-willpower-you-can-do-it-new-york-times/#comments</comments>
		<pubDate>Thu, 06 Dec 2007 21:28:23 +0000</pubDate>
		<dc:creator>Phil</dc:creator>
				<category><![CDATA[In the News]]></category>
		<category><![CDATA[Office Affirmations -- Thought for the Day]]></category>
		<category><![CDATA[Outside Insights]]></category>

		<guid isPermaLink="false">http://www.addexecutive.com/2007/12/06/impulse-control-and-willpower-you-can-do-it-new-york-times/</guid>
		<description><![CDATA[Some naysayers argue that attention deficit disorder isn&#8217;t a real problem, or that it&#8217;s only a problem for people who fail to take personal responsibility for their brains and behaviors. Admittedly, many past ADD-management have relied too broadly on medication with little focus on self-management. Things are better today with greater use of additional techniques [...]]]></description>
		<wfw:commentRss>http://www.addexecutive.com/2007/12/06/impulse-control-and-willpower-you-can-do-it-new-york-times/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>S. Korean Camp Therapy for Internet Addiction</title>
		<link>http://www.addexecutive.com/2007/11/17/s-korean-camp-therapy-for-internet-addiction/</link>
		<comments>http://www.addexecutive.com/2007/11/17/s-korean-camp-therapy-for-internet-addiction/#comments</comments>
		<pubDate>Sun, 18 Nov 2007 03:28:30 +0000</pubDate>
		<dc:creator>Phil</dc:creator>
				<category><![CDATA[ADD Triggers]]></category>
		<category><![CDATA[In the News]]></category>

		<guid isPermaLink="false">http://www.addexecutive.com/2007/11/17/s-korean-camp-therapy-for-internet-addiction/</guid>
		<description><![CDATA[For people with attention deficit disorder, is compulsive internet surfing an example of no focus or an example of hyperfocus?  On the one hand, the addicted surfer is constantly moving from one website to another.  On the other hand, the addicted surfer is clearly focused on one thing: &#8220;the internet&#8221; and the computer he&#8217;s using [...]]]></description>
		<wfw:commentRss>http://www.addexecutive.com/2007/11/17/s-korean-camp-therapy-for-internet-addiction/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>&#8220;Management by Walking Around&#8221;</title>
		<link>http://www.addexecutive.com/2007/11/09/management-by-walking-around/</link>
		<comments>http://www.addexecutive.com/2007/11/09/management-by-walking-around/#comments</comments>
		<pubDate>Sat, 10 Nov 2007 03:13:25 +0000</pubDate>
		<dc:creator>Phil</dc:creator>
				<category><![CDATA[Articles]]></category>
		<category><![CDATA[In the News]]></category>
		<category><![CDATA[Outside Insights]]></category>
		<category><![CDATA[Quotes]]></category>
		<category><![CDATA[Reviews -- Books]]></category>

		<guid isPermaLink="false">http://www.addexecutive.com/2007/11/09/management-by-walking-around/</guid>
		<description><![CDATA[I learned that quality requires minute attention to every detail, that everyone in an organization wants to do a good job, that written instructions are seldom adequate, and that personal involvement needs to be frequent, friendly, unfocused, and unscheduled—but far from pointless. And since its principal aim is to seek out people&#8217;s thoughts and opinions, [...]]]></description>
		<wfw:commentRss>http://www.addexecutive.com/2007/11/09/management-by-walking-around/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Caffeine in your Decaf Coffee</title>
		<link>http://www.addexecutive.com/2007/10/30/caffeine-in-your-decaf-coffee/</link>
		<comments>http://www.addexecutive.com/2007/10/30/caffeine-in-your-decaf-coffee/#comments</comments>
		<pubDate>Tue, 30 Oct 2007 05:01:03 +0000</pubDate>
		<dc:creator>Phil</dc:creator>
				<category><![CDATA[Articles]]></category>
		<category><![CDATA[In the News]]></category>
		<category><![CDATA[Reference -- Pharma, Meds, Drugs]]></category>

		<guid isPermaLink="false">http://www.addexecutive.com/2007/10/30/caffeine-in-your-decaf-coffee/</guid>
		<description><![CDATA[Do you use caffeine to treat your attention deficit disorder? Or do you avoid caffeine at night to protect your mission-critical sleep? In either case, you probably ought know how much you&#8217;re taking and when. Problem is, if you&#8217;re drinking decaf coffee, you can&#8217;t always be sure. Excerpt from A Wake-Up Call for Coffee Drinkers, [...]]]></description>
		<wfw:commentRss>http://www.addexecutive.com/2007/10/30/caffeine-in-your-decaf-coffee/feed/</wfw:commentRss>
		<slash:comments>1</slash:comments>
		</item>
		<item>
		<title>&#8220;Interim Sprint CEO Sets Out To Restore Company&#8217;s Focus&#8221; &#8211; Washington Post</title>
		<link>http://www.addexecutive.com/2007/10/19/interim-sprint-ceo-sets-out-to-restore-companys-focus-washington-post/</link>
		<comments>http://www.addexecutive.com/2007/10/19/interim-sprint-ceo-sets-out-to-restore-companys-focus-washington-post/#comments</comments>
		<pubDate>Sat, 20 Oct 2007 04:02:13 +0000</pubDate>
		<dc:creator>Phil</dc:creator>
				<category><![CDATA[In the News]]></category>
		<category><![CDATA[Office Affirmations -- Thought for the Day]]></category>
		<category><![CDATA[Quotes]]></category>

		<guid isPermaLink="false">http://www.addexecutive.com/2007/10/19/interim-sprint-ceo-sets-out-to-restore-companys-focus-washington-post/</guid>
		<description><![CDATA[When you feel your company is struggling to stay focused, take heart in knowing that even the biggest companies &#8212; with their monster budgets for hiring smart people &#8212; often have the same problem. Here&#8217;s an excerpt of the Washington Post&#8217;s coverage of focus problems at Sprint Nextel Interim Sprint CEO Sets Out To Restore [...]]]></description>
		<wfw:commentRss>http://www.addexecutive.com/2007/10/19/interim-sprint-ceo-sets-out-to-restore-companys-focus-washington-post/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>FDA: New Warning for Serious Skin Rash with Provigil</title>
		<link>http://www.addexecutive.com/2007/10/08/fda-new-warning-for-serious-skin-rash-with-provigil/</link>
		<comments>http://www.addexecutive.com/2007/10/08/fda-new-warning-for-serious-skin-rash-with-provigil/#comments</comments>
		<pubDate>Mon, 08 Oct 2007 06:06:52 +0000</pubDate>
		<dc:creator>Phil</dc:creator>
				<category><![CDATA[In the News]]></category>
		<category><![CDATA[Reference -- Pharma, Meds, Drugs]]></category>

		<guid isPermaLink="false">http://www.addexecutive.com/2007/10/08/fda-new-warning-for-serious-skin-rash-with-provigil/</guid>
		<description><![CDATA[Modafinil (marketed as Provigil): Serious Skin ReactionsFDA has been monitoring cases of serious skin reactions, including erythema multiforme (EM), Stevens-Johnson syndrome (SJS), and toxic epidermal necrolysis (TEN), in its postmarketing reviews of adverse event reports associated with the use of modafinil. The product labeling for modafinil has been recently updated to include a bolded warning [...]]]></description>
		<wfw:commentRss>http://www.addexecutive.com/2007/10/08/fda-new-warning-for-serious-skin-rash-with-provigil/feed/</wfw:commentRss>
		<slash:comments>2</slash:comments>
		</item>
	</channel>
</rss>
